Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study von Kister, Ilya, Spelman, Tim, Alroughani, Raed, Lechner-Scott, Jeannette, Duquette, Pierre, Grand'Maison, Francois, Slee, Mark, Lugaresi, Alessandra, Barnett, Michael, Grammond, Pierre, Iuliano, Gerardo, Hupperts, Raymond, Pucci, Eugenio, Trojano, Maria, Butzkueven, Helmut

Volltext

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis von Kalincik, Tomas, Horakova, Dana, Spelman, Tim, Jokubaitis, Vilija, Trojano, Maria, Lugaresi, Alessandra, Izquierdo, Guillermo, Rozsa, Csilla, Grammond, Pierre, Alroughani, Raed, Duquette, Pierre, Girard, Marc, Pucci, Eugenio, Lechner-Scott, Jeannette, Slee, Mark, Fernandez-Bolanos, Ricardo, Grand'Maison, Francois, Hupperts, Raymond, Verheul, Freek, Hodgkinson, Suzanne, Oreja-Guevara, Celia, Spitaleri, Daniele, Barnett, Michael, Terzi, Murat, Bergamaschi, Roberto, McCombe, Pamela, Sanchez-Menoyo, Jose, Simo, Magdolna, Csepany, Tunde, Rum, Gabor, Boz, Cavit, Havrdova, Eva, Butzkueven, Helmut

Volltext

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS von Ribbons, Karen Ann, McElduff, Patrick, Boz, Cavit, Trojano, Maria, Izquierdo, Guillermo, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois, Hupperts, Raymond, Grammond, Pierre, Oreja-Guevara, Celia, Petersen, Thor, Bergamaschi, Roberto, Giuliani, Giorgio, Barnett, Michael, van Pesch, Vincent, Amato, Maria-Pia, Iuliano, Gerardo, Fiol, Marcela, Slee, Mark, Verheul, Freek, Cristiano, Edgardo, Fernandez-Bolanos, Ricardo, Saladino, Maria-Laura, Rio, Maria Edite, Cabrera-Gomez, Jose, Butzkueven, Helmut, van Munster, Erik, Den Braber-Moerland, Leontien, La Spitaleri, Daniele, Lugaresi, Alessandra, Shaygannejad, Vahid, Gray, Orla, Deri, Norma, Alroughani, Raed, Lechner-Scott, Jeannette

Volltext

Geographical variations in sex ratio trends over time in multiple sclerosis von Trojano, Maria

Volltext

DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes von Xavier, Alexandre, Maltby, Vicki E, Ewing, Ewoud, Campagna, Maria Pia, Burnard, Sean M, Tegner, Jesper N, Slee, Mark, Butzkueven, Helmut, Kockum, Ingrid, Kular, Lara, Jokubaitis, Vilija G, Kilpatrick, Trevor, Alfredsson, Lars, Jagodic, Maja, Ponsonby, Anne-Louise, Taylor, Bruce V, Scott, Rodney J, Lea, Rodney A, Lechner-Scott, Jeannette

Volltext

Evaluating the Ability of Open-Source Artificial Intelligence to Predict Accepting-Journal Impact Factor and Eigenfactor Score Using Academic Article Abstracts: Cross-sectional Mac... von Macri, Carmelo, Bacchi, Stephen, Teoh, Sheng Chieh, Lim, Wan Yin, Lam, Lydia, Patel, Sandy, Slee, Mark, Casson, Robert, Chan, WengOnn

Volltext

The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform von Jokubaitis, Vilija G, Spelman, Tim, Lechner-Scott, Jeannette, Barnett, Michael, Shaw, Cameron, Vucic, Steve, Liew, Danny, Butzkueven, Helmut, Slee, Mark

Volltext

Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis von Campagna, Maria Pia, Xavier, Alexandre, Stankovich, Jim, Maltby, Vicki E, Slee, Mark, Yeh, Wei Z, Kilpatrick, Trevor, Scott, Rodney J, Butzkueven, Helmut, Lechner-Scott, Jeannette, Lea, Rodney A, Jokubaitis, Vilija G

Volltext

Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies von Butzkueven, Helmut, Kalincik, Tomas, Patti, Francesco, Slee, Mark, Weinstock-Guttman, Bianca, Buzzard, Katherine, Skibina, Olga, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Horakova, Dana, Havrdova, Eva Kubala, Van der Walt, Anneke, Eichau, Sara, Hyde, Robert, Campbell, Nolan, Bodhinathan, Karthik, Spelman, Tim

Volltext

3 Managing disease activity during treatment with natalizumab in relapsing-remitting multiple sclerosis von Lizak, Nathaniel, Sharmin, Sifat, Walt, Anneke Van der, Butzkueven, Helmut, Lechner-Scott, Jeanette, Buzzard, Katherine, Skibina, Olga, Hodgkinson, Suzanne, Slee, Mark, John, Nevin, Roos, Izanne, Kalincik, Tomas

Volltext

3149 Real-world Australian experience with Ofatumumab in the MSBase registry von Migocki, Margaret, Walt, Anneke Van der, Butzkueven, Helmut, Spelman, Tim, Kermode, Allan, Fabis-Pedrini, Marzena, Carroll, William M, Lechner-Scott, Jeannette, John, Nevin, Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Kalincik, Tomas, Macdonell, Richard, Slee, Mark, Schmitt, Birte

Volltext

The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease von Parnell, Grant P, Gatt, Prudence N, Krupa, Malgorzata, Nickles, Dorothee, McKay, Fiona C, Schibeci, Stephen D, Batten, Marcel, Baranzini, Sergio, Henderson, Andrew, Barnett, Michael, Slee, Mark, Vucic, Steve, Stewart, Graeme J, Booth, David R

Volltext

The Northern Territory Medical Program - growing our own in the NT von Worley, Paul, Lowe, Michael, Notaras, Leonard, Strasser, Sarah, Kidd, Michael, Slee, Mark, Williams, Rhys, Noutsos, Tina, Wakerman, John

Volltext

Glucocorticoid‐induced adrenal suppression: physiological basis and strategies for glucocorticoid weaning von Bacchi, Stephen, Tan, Sheryn, Slee, Mark

Volltext

Fingolimod after natalizumab and the risk of short-term relapse von JOKUBAITIS, Vilija G, LI, Vivien, BARNETT, Michael, GRAND'MAISON, Francois, TROJANO, Maria, SLEE, Mark, GIULIANI, Giorgio, SHAW, Cameron, BOZ, Cavit, SPITALERI, Daniele L. A, VERHEUL, Freek, HAARTSEN, Jodi, KALINCIK, Tomas, LIEW, Danny, BUTZKUEVEN, Helmut, IZQUIERDO, Guillermo, HODGKINSON, Suzanne, ALROUGHANI, Raed, LECHNER-SCOTT, Jeannette, LUGARESI, Alessandra, DUQUETTE, Pierre, GIRARD, Marc

Volltext

Minimising harm: avoiding intubation for psychogenic non‐epileptic seizures von Bacchi, Stephen, Verghese, Santosh, Slee, Mark

Volltext

Functional Characterisation of the Circular RNA, circHTT(2-6) , in Huntington's Disease von Gantley, Laura, Stringer, Brett W, Conn, Vanessa M, Ootsuka, Youichirou, Holds, Duncan, Slee, Mark, Aliakbari, Kamelya, Kirk, Kirsty, Ormsby, Rebecca J, Webb, Stuart T, Hanson, Adrienne, Lin, He, Selth, Luke A, Conn, Simon J

Volltext

010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort von Butzkueven, Helmut, Spelman, Tim, Kalincik, Tomas, Buzzard, Katherine, Walt, Anneke Van der, Lechner-Scott, Jeanette, Hodgkinson, Suzanne, Butler, Ernest, Macdonell, Richard, Slee, Mark, Group, MSBase Study, Marcel, Bruno

Volltext

Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: A case report and literature review von Sylvester, Jessica, Purdie, Grant, Slee, Mark, Gray, James X, Burnet, Simon, Koblar, Simon

Volltext

008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis von Roos, Izanne, Malpas, Charles B, Leray, Emmanuelle, Buzzard, Katherine, Skibina, Olga, Lechner-Scott, Jeannette, McCombe, Pamela, Slee, Mark, Butler, Ernest, Macdonell, Richard, Walt, Anneke van der, Hodgkinson, Suzanne, Barnett, Michael, Vucic, Steve, Vukusic, Sandra, Butzkueven, Helmut, Kalincik, Tomas

Volltext